Objective: A dosimetric study was performed to evaluate the performance of volumetric modulated arc radiotherapy with RapidArc on locally advanced nasopharyngeal carcinoma (NPC).
INTRODUCTION
Recently, nasopharyngeal carcinoma (NPC) patients more likely have received intensity-modulated radiotherapy (IMRT) than three dimensionals' conformal radiotherapy (3D-CRT). The IMRT has got better dose distribution in target volume and lower dose for organs at risk (OARs), especially for the parotids [1] [2] [3] . But IMRT iiiiiiiiiii  needs complex plan management, more fixed fields and monitor units (MUs) especially for NPC which has large target volume, more OARs and more overlapping of target volume. All of the above may bring the prolonging of the treatment time (for example, 7-9 fixed-field dynamic IMRT needs about 7-10 minutes of treatment delivery) which may cause the increasing of the movement of the swallowing and the position shift during the treatment, so that the clinical efficacy may be reduced consequently.
Generally, the number of the fixed fields can increase the freedom of the plan management, and the development of the volumetric modulated arc therapy technique brings the design of the treatment plan to a new stage which can produce various optimization methods based on the differences of the peak value optimization [4] . Nowadays, RapidArc was developed mainly by the optimization of the multi-leaf collimators shape, the change of the dose rate delivery and the rotation of the gantry [5] [6] [7] [8] . It was based on the volumetric modulated arc therapy technique and can obtain the similar distribution of the fixed IMRT. The analytical anisotropic algorithm (AAA) system was used for dose calculation [9] , and GLAaS [10] and PTW-729 [11] methods were applied for quality control to ensure the accuracy and security in the clinical application [12] .
Currently, multiple centers compared the dose distribution of the both techniques and generally suggested that volumetric modulated arc therapy with RapidArc was a rapid, safe and accurate radiotherapy technique for many tumors like gliomas, brain metastases and some lung tumors according to the preliminary results [13] [14] [15] [16] [17] .
NPC needs large and complex target volume and has many OARs around, so that complicated fields' management was necessary. Therefore, in this study, RapidArc was compared at the reference of the fixed 9-field IMRT in dosimetry for locally advanced NPC.
MATERIALS AND METHODS

Patients' Characteristics
Twenty cases of location CT scan data (layer 3 mm) was randomly selected from the locally advanced NPC patients who had received radiotherapy (RT) continuously in Radiotherapy Department, Beijing Cancer Hospital. The patients' characteristics are shown in Table 1 , and the clinical stage was according to the Stage of NPC (AJCC 2002) followed as below. Among these 20 patients, three patients had been diagnosed as T4 and six patients as N3. The gross tumor volume (GTV) was ranged from 51.4 cm 3 to 421.8 cm 3 and the median volume was 130.9±83.2 cm 3 . Treatment Plan Management Two treatment plans were performed for each patient. RapidArc was compared to the fixed 9-field coplanar dynamic IMRT in dosimetry. The Eclipse system from the Varian Company (Denver, USA) was used for the two RT plans, with 6MV-X ray and 120 multi-leaf collimator in it. Considering the large target volume of the locally advanced NPC and complex OARs around, the double-arc plan was adopted for RapidArc and the coplanar fixed 9-field plan was selected for IMRT. Meantime, the AAA 8.6 edition system was applied for calculation.
The simultaneous boost plan was used and the dose prescribed as: GTV 70 Gy/33f, 95% planning target volume (PTV) 60 Gy/33f was generated by 5-mm outer margin of clinical target volume (CTV) and 5 mm apart from the skin at least.
The quality control of the plan was in accordance with the standard dose-volume histogram (DVH) of D 98% and D 2% which represent the doses of 98% and 2% PTV and they indicated the minimum and maximum doses of the plan respectively. The conformity index (CI) of the target volume is expressed as CI 95% =(PTV 60Gy / V PTV )×(PTV 60Gy /V 60Gy ) [18] . PTV 60Gy represents the volume receiving the prescription dose 60 Gy in the target volume, V PTV stands for the volume of the PTV, V 60Gy is in the name of the volume which has received the prescribed dose. The homogeneity index (HI) of the target volume is defined as HI=100×[1(D 5% D 95% )/ D mean ] [15] . OARs, D 33% , D mean , D 50% , and D 66% were adopted to evaluate the dose distribution of both sides of the parotids. D mean and D max (the maximum dose which was defined as the dose received by less than 2 ml volume of the following OARs) were applied to evaluate the dose of the lens, spinal cord, mandible and optic nerves. For the healthy tissue, integrity absorption dose (DoseInt) was used as the evaluation standard accompanied by D mean and V 10Gy at the same time. The time interval of the treatment delivery and the MU values of the techniques were also compared.
Statistical Analyses
The SPSS 13.0 (SPSS Inc., IL, USA) was applied for statistical data management and analysis, and doubleside t-test was employed to compare the difference between two treatment plans at statistically significant level of P<0.05. The null hypothesis of no difference in dosimetry between study groups was tested with the use of the log-rank test at a two-sided level of significance of 0.05. Confidence intervals were calculated and study groups were compared by means of the log-rank test. All other hypothesis tests were two-sided at a significance level of 0.05. Table 2 shows the comparison of the dose distribution of the PTVs and the CI and HI of the target volumes. According to the clinical requirement, D mean and D max of the PTV were lower while D min was slightly higher and statistically significant for IMRT. The CI 95% of RapidArc and IMRT were both 0.78±0.07 (P>0.05). However, the HI for RapidArc and IMRT were 78.9±1.3 and 80.4±0.5, respectively (P<0.05). Table 3 manifests the dose comparison of the OARs for the two plans. As we can see, the plans were similar in the mean dose of the spinal cord and had no differences at statistically significant levels (P<0.05). With
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